Related Experiment Video

Updated: Aug 30, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Dysregulation of cellular signaling by HER2/neu in breast cancer

Binhua P Zhou1, Mien-Chie Hung

  • 1Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Seminars in Oncology
|November 13, 2003
PubMed

Insights

Human epidermal growth factor receptor-2 (HER2/neu) overexpression in breast cancer drives poor outcomes. Understanding HER2/neu pathways offers new therapeutic targets for breast and ovarian cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Human epidermal growth factor receptor-2 (HER2/neu; erbB2) is a receptor tyrosine kinase crucial for cell growth.
  • HER2/neu amplification/overexpression is found in 30% of breast and ovarian cancers, correlating with poor prognosis.
  • This overexpression is linked to shorter survival and faster relapse rates.

Purpose of the Study:

  • To review the signaling network mediated by HER2/neu in breast cancer.
  • To discuss the importance of these pathways in breast cancer tumorigenesis.
  • To highlight HER2/neu as a therapeutic target for HER2/neu-overexpressing tumors.

Main Methods:

  • Literature review of HER2/neu signaling pathways.
  • Analysis of HER2/neu's role in breast cancer cell survival and growth.
  • Focus on advances in understanding HER2/neu-mediated tumorigenesis.

Main Results:

  • HER2/neu signaling pathways are critical for cell survival and growth in breast cancer.
  • Understanding these pathways enhances knowledge of breast cancer development.
  • HER2/neu pathways provide potential targets for novel cancer therapies.

Conclusions:

  • Targeting HER2/neu signaling pathways is crucial for treating breast and ovarian cancers.
  • Advances in understanding HER2/neu pathways offer new hope for patients.
  • HER2/neu plays a significant role in mediating cell survival and proliferation in various cancer contexts.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Autocrine Signaling01:54

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.Autocrine Signaling in MacrophagesUnder normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...